Literature DB >> 30559420

Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect.

Artur V Cideciyan1, Samuel G Jacobson2, Arlene V Drack3, Allen C Ho4, Jason Charng5, Alexandra V Garafalo5, Alejandro J Roman5, Alexander Sumaroka5, Ian C Han3, Maria D Hochstedler3, Wanda L Pfeifer3, Elliott H Sohn3, Magali Taiel6, Michael R Schwartz6, Patricia Biasutto6, Wilma de Wit6, Michael E Cheetham7, Peter Adamson6,7, David M Rodman6, Gerard Platenburg6, Maria D Tome6, Irina Balikova8, Fanny Nerinckx8, Julie De Zaeytijd8, Caroline Van Cauwenbergh8, Bart P Leroy8, Stephen R Russell3.   

Abstract

Photoreceptor ciliopathies constitute the most common molecular mechanism of the childhood blindness Leber congenital amaurosis. Ten patients with Leber congenital amaurosis carrying the c.2991+1655A>G allele in the ciliopathy gene centrosomal protein 290 (CEP290) were treated (ClinicalTrials.gov no. NCT03140969 ) with intravitreal injections of an antisense oligonucleotide to restore correct splicing. There were no serious adverse events, and vision improved at 3 months. The visual acuity of one exceptional responder improved from light perception to 20/400.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30559420     DOI: 10.1038/s41591-018-0295-0

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  68 in total

Review 1.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

2.  Progress of macular atrophy during 30 months' follow-up in a patient with spinocerebellar ataxia type1 (SCA1).

Authors:  Ayane Hirose; Satoshi Katagiri; Takaaki Hayashi; Tomokazu Matsuura; Norihiro Nagai; Kaoru Fujinami; Takeshi Iwata; Kazushige Tsunoda
Journal:  Doc Ophthalmol       Date:  2020-07-09       Impact factor: 2.379

Review 3.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

Review 4.  Healthcare recommendations for Joubert syndrome.

Authors:  Ruxandra Bachmann-Gagescu; Jennifer C Dempsey; Sara Bulgheroni; Maida L Chen; Stefano D'Arrigo; Ian A Glass; Theo Heller; Elise Héon; Friedhelm Hildebrandt; Nirmal Joshi; Dana Knutzen; Hester Y Kroes; Stephen H Mack; Sara Nuovo; Melissa A Parisi; Joseph Snow; Angela C Summers; Jordan M Symons; Wadih M Zein; Eugen Boltshauser; John A Sayer; Meral Gunay-Aygun; Enza Maria Valente; Dan Doherty
Journal:  Am J Med Genet A       Date:  2019-11-11       Impact factor: 2.802

5.  Transient pupillary light reflex in CEP290- or NPHP5-associated Leber congenital amaurosis: Latency as a potential outcome measure of cone function.

Authors:  Arun K Krishnan; Samuel G Jacobson; Alejandro J Roman; Bhavya S Iyer; Alexandra V Garafalo; Elise Héon; Artur V Cideciyan
Journal:  Vision Res       Date:  2020-02-20       Impact factor: 1.886

Review 6.  Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.

Authors:  Albert M Maguire; Jean Bennett; Elena M Aleman; Bart P Leroy; Tomas S Aleman
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

Review 7.  An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.

Authors:  Wei Chiu; Ting-Yi Lin; Yun-Chia Chang; Henkie Isahwan-Ahmad Mulyadi Lai; Shen-Che Lin; Chun Ma; Aliaksandr A Yarmishyn; Shiuan-Chen Lin; Kao-Jung Chang; Yu-Bai Chou; Chih-Chien Hsu; Tai-Chi Lin; Shih-Jen Chen; Yueh Chien; Yi-Ping Yang; De-Kuang Hwang
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

8.  Antisense Oligonucleotide-Based Rescue of Aberrant Splicing Defects Caused by 15 Pathogenic Variants in ABCA4.

Authors:  Tomasz Z Tomkiewicz; Nuria Suárez-Herrera; Frans P M Cremers; Rob W J Collin; Alejandro Garanto
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 9.  Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.

Authors:  Alexandra V Garafalo; Artur V Cideciyan; Elise Héon; Rebecca Sheplock; Alexander Pearson; Caberry WeiYang Yu; Alexander Sumaroka; Gustavo D Aguirre; Samuel G Jacobson
Journal:  Prog Retin Eye Res       Date:  2019-12-30       Impact factor: 21.198

Review 10.  From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies.

Authors:  Hironori Adachi; Martin Hengesbach; Yi-Tao Yu; Pedro Morais
Journal:  Biomedicines       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.